Technology
Primorus Investments invests in Pri0r1ty AI
Primorus Investments announced a new strategic investment on Friday, subscribing for 18,100,000 ordinary shares in Pri0r1ty AI for £0. 3m.
Jaywing revenue falls but adjusted earnings rise
Shares in data science and marketing company Jaywing were jumping on Friday, as it reported its audited financial results for the year ended 31 March.
Bigblu revenue slips as it moves customers to higher-value packages
Bigblu Broadband reported a decline in first-half revenue on Friday, to £11. 2m from £13m in the same period last year, reflecting a strategic decision to migrate customers onto higher-value packages.
Vela Technologies reports big drop in asset value
Vela Technologies, an AIM-listed company focussed on early-stage and pre-IPO disruptive technology investments, reported a significant decrease in its asset value for the quarter ended 30 June on Friday.
Zenova reports solid momentum as interim loss narrows
Fire safety and heat management technology specialist Zenova Group reported significant first-half strides in its interim results on Friday, despite a challenging financial backdrop.
STV taps ITV's Rufus Radcliffe as its new CEO
STV Group announced the appointment of Rufus Radcliffe as its new chief executive officer on Friday, effective 1 November.
Best Buy lifts profit guidance after Q2 comparable sales beat
Best Buy hiked its profit forecast for the year on Thursday, amid a positive shift in consumer demand for electronics.
Tracsis ends year in line with revised guidance
Tracsis said in an update on Thursday that its financial performance for the year ended 31 July was in line with revised guidance, despite a challenging operational environment.
Judges Scientific's Geotek wins binding coring contract
Judges Scientific, a specialist in the acquisition and development of businesses in the scientific instrument sector, announced on Thursday that its subsidiary Geotek had secured a binding contract for an upcoming coring expedition.
Hyundai Motor lays out ambitious goals for sales, shareholder returns
Hyundai Motor announced ambitious plans to increase its annual global sales by 30% to 5. 55 million vehicles by 2030 on Wednesday, with a significant focus on expanding its hybrid vehicle lineup.
Aquis Exchange confident despite loss of historic contract
Aquis Exchange updated the market on its recent trading on Wednesday, highlighting modest revenue growth, a strong cash position, and strategic investments aimed at expanding its technology division, although it warned of a £1m hit from the loss of a historic contract.
Polarean appoints Xenon MRI specialist as chief medical advisor
Advanced MRI technology specialist Polarean Imaging announced the appointment of Dr Chase Hall as its chief medical advisor on Wednesday.
Seeing Machines full-year revenue rises, losses widen
Driver monitoring technology company Seeing Machines reported a robust performance for the 2024 financial year in an update on Wednesday, with significant growth in revenue, expansion of its automotive programs, and strategic partnerships.
Faron Pharmaceuticals candidate gets FDA fast track designation
Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Tuesday that its lead candidate, bexmarilimab, has been granted fast track designation by the US Food and Drug Administration (FDA), for the treatment of relapsed or refractory myelodysplastic syndrome (r/r MDS) in combination with azacitidine.
Diaceutics reports progress with rare-disease offerings
Diaceutics announced a significant enhancement to its rare-disease offerings on Tuesday, leading to the acquisition of a new contract aimed at supporting the commercialisation of a rare-disease therapy.
Belluscura shares surge on strong sales momentum, improved outlook
Belluscura, a developer of lightweight and portable oxygen enrichment technology, reported strong sales momentum and an optimistic trading outlook on Tuesday, as it prepared for the full commercial launch of its new ‘DISCOV-R’ portable oxygen concentrator.
RUA Life Sciences reports strong start to financial year
RUA Life Sciences, a medical device company specialising in implantable textiles and biostable polymers, reported a strong start to its financial year on Tuesday, with trading in the first four months exceeding management expectations.
Shield Therapeutics iron deficiency treatment approved in Canada
Commercial-stage pharmaceutical company Shield Therapeutics announced on Tuesday that ‘ACCRUFeR’, or ferric maltol, had been approved by Health Canada as a prescription drug for the treatment of adults with iron deficiency anaemia (IDA).
JD.com unveils $5bn, 36-month share buyback plans
Chinese e-commerce giant JD. com unveiled a new $5bn share buyback programme on Tuesday, set to begin in September and extend over the next 36 months.
Bronfman withdraws bid for Paramount, making way for Skydance deal
Edgar Bronfman Jr officially withdrew his bid to acquire Paramount Global on Tuesday, effectively clearing the way for Skydance Media to take control of the company.